PRKDC and glioblastoma: To investigate the impact of DNA-PKcs status on glioblastoma cell survival after α particle irradiation, we assessed both long-term clonogenic survival and short-term MTT metabolic activity in M059J (DNA-PKcs-deficient) and M059K (DNA-PKcs-proficient) cells across a range of doses (0–2.67 Gy).